The Worldwide Biologics Contract Development & Manufacturing Organization Industry is Projected to Reach $12.5 Billion by 2027 at a 12.23% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--Nov 22, 2022--

The "Biologics Contract Development & Manufacturing Organization Market Research Report by Type, Product Type, Disease Indication, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Biologics Contract Development & Manufacturing Organization Market size was estimated at USD 6,291.23 million in 2021, USD 7,044.93 million in 2022, and is projected to grow at a CAGR of 12.23% to reach USD 12,574.91 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biologics Contract Development & Manufacturing Organization Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biologics Contract Development & Manufacturing Organization Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biologics Contract Development & Manufacturing Organization Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biologics Contract Development & Manufacturing Organization Market?

4. What is the competitive strategic window for opportunities in the Global Biologics Contract Development & Manufacturing Organization Market?

5. What are the technology trends and regulatory frameworks in the Global Biologics Contract Development & Manufacturing Organization Market?

6. What is the market share of the leading vendors in the Global Biologics Contract Development & Manufacturing Organization Market?

7. What modes and strategic moves are considered suitable for entering the Global Biologics Contract Development & Manufacturing Organization Market?

Companies Mentioned

• AbbVie Inc.
• Abzena Ltd
• AGC Biologics
• Bionova Scientific, Inc.
• Boehringer Ingelheim Biopharmaceuticals GmbH
• Catalent Inc.
• Curia Global, Inc.
• FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
• GenScript Biotech Corporation
• Icon PLC
• JRS PHARMA GmbH & Co. KG
• KBI Biopharma Inc.
• Parexel International Corporation
• Rentschler Biopharma SE
• Samsung Biologics
• Sandoz International GmbH
• STC Biologics, Inc.
• Thermo Fisher Scientific Inc.
• Toyobo Co. Limited
• WuXi Biologics Inc.

For more information about this report visit https://www.researchandmarkets.com/r/aqpha0

View source version on businesswire.com:https://www.businesswire.com/news/home/20221122005390/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2022.